COPT Defense Properties (CDP)

NYSE · Real Estate · REIT - Office · USA

COPT Defense Properties is a mid cap company (market value between $2 billion and $10 billion) in the REIT - Office industry.

COPT Defense Properties is a real estate investment trust that owns, operates and develops properties near U.S. Government defense installations and missions. Its portfolio consists primarily of office properties and data center shells leased to the federal government and defense contractors. The company controls substantial developable land across key defense hubs.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the COPT Defense Properties stock.

Our verdict on CDP

Overvalued: intrinsic value $19.83 per share, market price $33.31, margin of safety -68.0% (as of 2026-10-20).

Discounting its cash flows at 8.6% (average of 3 methods) values the shares at $19.83; the price of $33.31 is 68% above that value, and 78% of that value comes from beyond year five.

Leak Score: 42/100 on 11 of 12 signals (On Watch).

ETFs with the most weight in CDP

17 more funds hold it; the full list is part of the paid plan.

More on CDP

Browse

Peers in REIT - Office

All 20 REIT - Office stocks

Compare side by side

Cheaper than CDP in REIT - Office

2 more in this industry show a wider margin of safety.

Is CDP undervalued or overvalued?

CDP is overvalued (as of the 2026-10-20 close). Discounting its cash flows at 8.6% (average of 3 methods) values the shares at $19.83; the price of $33.31 is 68% above that value, and 78% of that value comes from beyond year five.

What is the intrinsic value of CDP?

$19.83 per share (as of the 2026-10-20 close), against a market price of $33.31. That is a margin of safety of -68.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is COPT Defense Properties's Leak Score?

42 out of 100, which we rate "On Watch", on 11 of 12 value investing signals.